Rosaxostat capsule
The invention provides a rosaxostat capsule. According to the invention, zinc oxide is used as an opacifying agent instead of titanium dioxide, so that the rosaxostat is prevented from photodegradation, the pharmacodynamic activity of the rosaxostat is further ensured, and the risk of genetic toxici...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TANG LIN HE YUXIA BAI PEIPEI SHANG SHUANG FENG MIN YANG XINXIN ZHANG QIAN SHENG LIDAN LI XINGYA LI SHAORU |
| description | The invention provides a rosaxostat capsule. According to the invention, zinc oxide is used as an opacifying agent instead of titanium dioxide, so that the rosaxostat is prevented from photodegradation, the pharmacodynamic activity of the rosaxostat is further ensured, and the risk of genetic toxicity caused by titanium dioxide is avoided.
本发明提供一种罗沙司他胶囊。本发明采用氧化锌替代二氧化钛作为遮光剂，避免罗沙司他产生光降解，进而确保其药效活性，同时避免二氧化钛带来的遗传毒性的风险。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116832005A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116832005A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116832005A3</originalsourceid><addsrcrecordid>eNrjZBAKyi9OrMgvLkksUUhOLCguzUnlYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GhmYWxkYGBqaOxsSoAQASwyAy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Rosaxostat capsule</title><source>esp@cenet</source><creator>TANG LIN ; HE YUXIA ; BAI PEIPEI ; SHANG SHUANG ; FENG MIN ; YANG XINXIN ; ZHANG QIAN ; SHENG LIDAN ; LI XINGYA ; LI SHAORU</creator><creatorcontrib>TANG LIN ; HE YUXIA ; BAI PEIPEI ; SHANG SHUANG ; FENG MIN ; YANG XINXIN ; ZHANG QIAN ; SHENG LIDAN ; LI XINGYA ; LI SHAORU</creatorcontrib><description>The invention provides a rosaxostat capsule. According to the invention, zinc oxide is used as an opacifying agent instead of titanium dioxide, so that the rosaxostat is prevented from photodegradation, the pharmacodynamic activity of the rosaxostat is further ensured, and the risk of genetic toxicity caused by titanium dioxide is avoided.
本发明提供一种罗沙司他胶囊。本发明采用氧化锌替代二氧化钛作为遮光剂，避免罗沙司他产生光降解，进而确保其药效活性，同时避免二氧化钛带来的遗传毒性的风险。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231003&DB=EPODOC&CC=CN&NR=116832005A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231003&DB=EPODOC&CC=CN&NR=116832005A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TANG LIN</creatorcontrib><creatorcontrib>HE YUXIA</creatorcontrib><creatorcontrib>BAI PEIPEI</creatorcontrib><creatorcontrib>SHANG SHUANG</creatorcontrib><creatorcontrib>FENG MIN</creatorcontrib><creatorcontrib>YANG XINXIN</creatorcontrib><creatorcontrib>ZHANG QIAN</creatorcontrib><creatorcontrib>SHENG LIDAN</creatorcontrib><creatorcontrib>LI XINGYA</creatorcontrib><creatorcontrib>LI SHAORU</creatorcontrib><title>Rosaxostat capsule</title><description>The invention provides a rosaxostat capsule. According to the invention, zinc oxide is used as an opacifying agent instead of titanium dioxide, so that the rosaxostat is prevented from photodegradation, the pharmacodynamic activity of the rosaxostat is further ensured, and the risk of genetic toxicity caused by titanium dioxide is avoided.
本发明提供一种罗沙司他胶囊。本发明采用氧化锌替代二氧化钛作为遮光剂，避免罗沙司他产生光降解，进而确保其药效活性，同时避免二氧化钛带来的遗传毒性的风险。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAKyi9OrMgvLkksUUhOLCguzUnlYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GhmYWxkYGBqaOxsSoAQASwyAy</recordid><startdate>20231003</startdate><enddate>20231003</enddate><creator>TANG LIN</creator><creator>HE YUXIA</creator><creator>BAI PEIPEI</creator><creator>SHANG SHUANG</creator><creator>FENG MIN</creator><creator>YANG XINXIN</creator><creator>ZHANG QIAN</creator><creator>SHENG LIDAN</creator><creator>LI XINGYA</creator><creator>LI SHAORU</creator><scope>EVB</scope></search><sort><creationdate>20231003</creationdate><title>Rosaxostat capsule</title><author>TANG LIN ; HE YUXIA ; BAI PEIPEI ; SHANG SHUANG ; FENG MIN ; YANG XINXIN ; ZHANG QIAN ; SHENG LIDAN ; LI XINGYA ; LI SHAORU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116832005A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TANG LIN</creatorcontrib><creatorcontrib>HE YUXIA</creatorcontrib><creatorcontrib>BAI PEIPEI</creatorcontrib><creatorcontrib>SHANG SHUANG</creatorcontrib><creatorcontrib>FENG MIN</creatorcontrib><creatorcontrib>YANG XINXIN</creatorcontrib><creatorcontrib>ZHANG QIAN</creatorcontrib><creatorcontrib>SHENG LIDAN</creatorcontrib><creatorcontrib>LI XINGYA</creatorcontrib><creatorcontrib>LI SHAORU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TANG LIN</au><au>HE YUXIA</au><au>BAI PEIPEI</au><au>SHANG SHUANG</au><au>FENG MIN</au><au>YANG XINXIN</au><au>ZHANG QIAN</au><au>SHENG LIDAN</au><au>LI XINGYA</au><au>LI SHAORU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Rosaxostat capsule</title><date>2023-10-03</date><risdate>2023</risdate><abstract>The invention provides a rosaxostat capsule. According to the invention, zinc oxide is used as an opacifying agent instead of titanium dioxide, so that the rosaxostat is prevented from photodegradation, the pharmacodynamic activity of the rosaxostat is further ensured, and the risk of genetic toxicity caused by titanium dioxide is avoided.
本发明提供一种罗沙司他胶囊。本发明采用氧化锌替代二氧化钛作为遮光剂，避免罗沙司他产生光降解，进而确保其药效活性，同时避免二氧化钛带来的遗传毒性的风险。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN116832005A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Rosaxostat capsule |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T13%3A19%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TANG%20LIN&rft.date=2023-10-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116832005A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |